Iranian Foreign Minister Mohammad Javad Zarif’s signal of flexibility this week regarding Western recognition of his nation’s right to enrich uranium offered heightened anticipation of an international deal as talks resumed on Wednesday in Geneva, the London Guardian reported.
Speaking on Tuesday, Zarif said Iran’s uranium-enrichment right is “non-negotiable” but his country sees “no necessity for its recognition as a right.”
The wording could remove the issue as an obstacle to agreement because of P-5+1 unease about explicitly granting in writing a right to engage in a process that many suspect Iran has used as an ostensibly peaceful cover for secretly moving toward a nuclear-arms capability.
This week’s confab constitutes the third such meeting since last month aimed at locking down an initial agreement on the Middle Eastern nation’s disputed nuclear activities, the New York Times reported.
Delegates from the six negotiating powers — China, France, Germany, Russia, the United Kingdom and the United States — began Wednesday’s discussions by coordinating with their top interlocutor, European Union foreign policy chief Catherine Ashton. Ashton was next slated to meet one-on-one with Zarif on Wednesday, prior to a Wednesday or Thursday gathering of all the participants.
Proposals under consideration at the planned three-day meeting in Geneva would grant Iran a degree of relief from international economic pressure in exchange for steps to help assure other countries that its atomic ambitions are strictly peaceful.
Both sides have indicated that they could yield some ground on key friction points that prevented them from reaching a deal in talks earlier this month, the Guardian reported on Tuesday. At that session, France pressed Tehran to halt preparation of a heavy-water reactor capable of generating bomb-usable plutonium upon completion, and Iran stressed its legal entitlement to enrich uranium — an activity that holds the potential to produce civilian atomic fuel as well as nuclear-bomb material.
France, for its part, is reportedly divided over its position on the Arak heavy-water site.
“There is a debate going on in Paris, between the Quai d’Orsay [the Foreign Ministry] and the Élysée [the presidency] on that position,” a French defense insider told the Guardian.
In a Wednesday attempt to reassure Iranian conservatives, the nation’s supreme religious leader said the government would adhere to strict limits on what it could concede, the Associated Press reported.
Ayatollah Ali Khamenei said that Tehran’s primary objective in the talks is “stabilization of the rights of the Iranian nation, including nuclear rights.”
What We're Following See More »
The Signal app is fast becoming the new favorite among those who are obsessed with the security and untraceabilty of their messaging. Just ask the Democratic National Committee. Or Edward Snowden. As Vanity Fair reports, before news ever broke that the DNC's servers had been hacked, word went out among the organization that the word "Trump" should never be used in their emails, lest it attract hackers' attention. Not long after, all Trump-related messages, especially disparaging ones, would need to be encrypted via the Snowden-approved Signal.
The Republican Study Committee may lose several members of the House Freedom Caucus next year, "potentially creating a split between two influential groups of House conservatives." The Freedom Caucus was founded at the inception of the current Congress by members who felt that the conservative RSC had gotten too cozy with leadership, "and its roughly 40 members have long clashed with the RSC over what tactics to use when pushing for conservative legislation." As many as 20 members may not join the RSC for the new Congress next year.
"The U.S. Food and Drug Administration on Monday issued emergency authorization for a Zika diagnostics test from Swiss drugmaker Roche, skirting normal approval channels as the regulator moves to fight the disease's spread." Meanwhile, the Wall Street Journal reports that a new study in Nature identifies "about a dozen substances" that could "suppress the pathogen's replication." Some of them are already in clinical trials.
According to 37 newly released audits, "some private Medicare plans overcharged the government for the majority of elderly patients they treated." A number of Medicare Advantage plans overstated "the severity of medical conditions like diabetes and depression." The money has since been paid back, though some plans are appealing the federal audits.